{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6576870",
  "DateCompleted": {
    "Year": "1983",
    "Month": "10",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0143-3334",
      "JournalIssue": {
        "Volume": "4",
        "Issue": "9",
        "PubDate": {
          "Year": "1983",
          "Month": "Sep"
        }
      },
      "Title": "Carcinogenesis",
      "ISOAbbreviation": "Carcinogenesis"
    },
    "ArticleTitle": "Effect of 13 cis retinoic acid on early precancerous antigenic goblet-cell modifications and induction of cancer during 1,2-dimethylhydrazine carcinogenesis in rats.",
    "Pagination": {
      "StartPage": "1175",
      "EndPage": "1178",
      "MedlinePgn": "1175-8"
    },
    "Abstract": {
      "AbstractText": [
        "The possible effect of oral 13 cis retinoic acid (13-cis-RA) on the carcinogenic process induced by 28 weekly s.c. injections of 1,2-dimethylhydrazine (DMH) in 34 Wistar rats was investigated. Using immunohistology, precancerous and cancerous stages were compared with the same stages induced by DMH without additional 13-cis-RA in 33 rats. M1 antigens, which characterize modifications in goblet-cell differentiation occurring early in rat colonic carcinogenesis, were used to investigate the possible effect of retinoids on differentiation during precancerous stages. From 3-20 weeks after the start of the experiment, no significant differences were observed in the timing of M1 antigens in the 2 groups of rats. It was also observed that 13-cis-RA had no effect on histological lesions associated with precancerous mucosa, nor on the occurrence of intestinal adenocarcinomas. Thus, under these conditions, oral administration of 13-cis-RA did not significantly inhibit precancerous or cancerous stages of intestinal carcinoma development."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Deca\u00ebns",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rosa",
        "ForeName": "B",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bara",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Daher",
        "ForeName": "N",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Burtin",
        "ForeName": "P",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Carcinogenesis",
    "NlmUniqueID": "8008055",
    "ISSNLinking": "0143-3334"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Carcinogens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Dimethylhydrazines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Methylhydrazines"
    },
    {
      "RegistryNumber": "5688UTC01R",
      "NameOfSubstance": "Tretinoin"
    },
    {
      "RegistryNumber": "EH28UP18IF",
      "NameOfSubstance": "Isotretinoin"
    },
    {
      "RegistryNumber": "IX068S9745",
      "NameOfSubstance": "1,2-Dimethylhydrazine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "1,2-Dimethylhydrazine"
    },
    {
      "QualifierName": [
        "chemically induced",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Carcinogens"
    },
    {
      "QualifierName": [
        "chemically induced",
        "pathology"
      ],
      "DescriptorName": "Colonic Neoplasms"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Dimethylhydrazines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "chemically induced",
        "pathology"
      ],
      "DescriptorName": "Intestinal Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Isotretinoin"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Methylhydrazines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Metastasis"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Neoplasms, Experimental"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology",
        "physiopathology"
      ],
      "DescriptorName": "Precancerous Conditions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Inbred Strains"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Tretinoin"
    }
  ]
}